Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Beirong Biogenetic Engineering is a biotechnology company based in Shanghai, China, specializing in the development and manufacture of molecular diagnostic reagents. Established in 1995, the company is a pioneer in the Chinese in vitro diagnostics (IVD) industry, focusing on nucleic acid testing technologies. Its core product portfolio includes PCR-based diagnostic kits for Human Papillomavirus (HPV), Hepatitis B (HBV), and Hepatitis C (HCV). The company's products are widely utilized in clinical settings for the screening, diagnosis, and monitoring of infectious diseases and viral loads. Shanghai Beirong was among the first enterprises in China to achieve GMP certification for diagnostic reagent production, maintaining a strong presence in the domestic healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Beirong Biogenetic Engineering.